PubMed

S100A4 overexpression proves to be independent marker for breast cancer progression.

Ismail NI, Kaur G, Hashim H, Hassan MS.

Cancer Cell Int. 2008 Sep 5;8:12.PMID: 18771601 [PubMed]Free PMC ArticleFree textRelated citations

Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression.

Ismail NI, Kaur G, Hashim H, Hassan MS.

Cancer Cell Int. 2008 May 5;8:6.PMID: 18454879 [PubMed]Free PMC ArticleFree textRelated citations

S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.

Zou M, Al-Baradie RS, Al-Hindi H, Farid NR, Shi Y.

Br J Cancer. 2005 Nov 28;93(11):1277-84.PMID: 16265347 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

[Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma]

Yu GZ, Wang JJ, Chen Y, Ni CR, Zhu MH.

Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Mar;9(2):165-9. Chinese. PMID: 16555162 [PubMed - indexed for MEDLINE]Related citations

BigH3 protein expression as a marker for breast cancer.

Calaf GM, Echiburú-Chau C, Zhao YL, Hei TK.

Int J Mol Med. 2008 May;21(5):561-8.PMID: 18425347 [PubMed - indexed for MEDLINE]Related citations

SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis.

Zhou X, Coad J, Ducatman B, Agazie YM.

Histopathology. 2008 Oct;53(4):389-402. Epub 2008 Jul 15.PMID: 18643929 [PubMed - indexed for MEDLINE]Related citations

Loss of annexin A1 expression in breast cancer progression.

Cao Y, Li Y, Edelweiss M, Arun B, Rosen D, Resetkova E, Wu Y, Liu J, Sahin A, Albarracin CT.

Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):530-4.PMID: 18776816 [PubMed - indexed for MEDLINE]Related citations

Overexpression of S100A4 is closely associated with progression of colorectal cancer.

Cho YG, Kim CJ, Nam SW, Yoon SH, Lee SH, Yoo NJ, Lee JY, Park WS.

World J Gastroenterol. 2005 Aug 21;11(31):4852-6.PMID: 16097057 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

A resampling-based meta-analysis for detection of differential gene expression in breast cancer.

Gur-Dedeoglu B, Konu O, Kir S, Ozturk AR, Bozkurt B, Ergul G, Yulug IG.

BMC Cancer. 2008 Dec 30;8:396.PMID: 19116033 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.

Zhou D, Pan G, Zheng C, Zheng J, Yian L, Teng X.

BMC Cancer. 2008 Nov 28;8:353.PMID: 19040718 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Aug 25;9:298.PMID: 19706168 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

MMP13 is potentially a new tumor marker for breast cancer diagnosis.

Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR.

Oncol Rep. 2009 Nov;22(5):1119-27.PMID: 19787229 [PubMed - indexed for MEDLINE]Related citations

Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.

Afify A, McNiel MA, Braggin J, Bailey H, Paulino AF.

Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):121-7.PMID: 18227732 [PubMed - indexed for MEDLINE]Related citations

Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.

Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z.

Mol Cancer Res. 2009 Jun;7(6):832-40. Epub 2009 Jun 16.PMID: 19531568 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.

Scholz C, Toth B, Barthell E, Mylonas I, Weissenbacher T, Friese K, Jeschke U.

Histol Histopathol. 2009 Apr;24(4):467-71.PMID: 19224449 [PubMed - indexed for MEDLINE]Related citations

Methylation-associated silencing of S100A4 expression in human epidermal cancers.

Li Y, Liu ZL, Zhang KL, Chen XY, Kong QY, Wu ML, Sun Y, Liu J, Li H.

Exp Dermatol. 2009 Oct;18(10):842-8. Epub 2009 Aug 23.PMID: 19703228 [PubMed - indexed for MEDLINE]Related citations

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102.PMID: 19338666 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.

Press MF, Finn RS, Cameron D, Di Leo A, Geyer CE, Villalobos IE, Santiago A, Guzman R, Gasparyan A, Ma Y, Danenberg K, Martin AM, Williams L, Oliva C, Stein S, Gagnon R, Arbushites M, Koehler MT.

Clin Cancer Res. 2008 Dec 1;14(23):7861-70.PMID: 19047115 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.

Kim JH, Kim CN, Kim SY, Lee JS, Cho D, Kim JW, Yoon SY.

Oncol Rep. 2009 Jul;22(1):41-7.PMID: 19513503 [PubMed - indexed for MEDLINE]Related citations

Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients.

Wang L, Wang X, Nie X, Ma L.

J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):354-8. Epub 2009 Jun 10.PMID: 19513621 [PubMed - in process]Related citations